The global clarityne market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Clarityne is a class of drugs that modify the histamine effects by reducing the histamine levels or blocking their receptors. Usually, the histamine 1 or H1 receptor is blocked to lessen the effects of the histamine secretion. Clarityne is commonly used to treat any allergic response caused by the hyper secretion of histamine, as in the case of allergic conjunctivitis along with temporary relief in minor allergic symptoms of the eye. The National Institutes of Health has stated in its 2017 report that the prevalence of conjunctivitis is nearly 6-30% in the general population and up to 30% in the children all across the globe. The major factors that drive the clarityne market growth are increasing incidences of allergic conditions that trigger the hyper production of histamine, sedentary lifestyle, and increase in environmental pollution. 

Emerging economies such as India also witness a high prevalence of the conjunctivitis. According to an article published by the journal - Clinical Epidemiology and Global Health, it was discovered that during the year 2019, the prevalence of allergic conjunctivitis was around 12.22% and the number of men suffering from this disease is higher than that of women in India. The epidemiology of the disease is similar in other Asian countries such as China. However, increased preference for complementary and alternative medicine (CAM) & side effects associated with drugs such as drowsiness restrain the market growth. In addition, continuous R&D in the field of clarityne drugs is expected to provide lucrative opportunities for the market.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Product

o By End-User

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape:  Bayer AG, Novartis International AG (Sandoz Pharmaceuticals AG), and Apotex Inc., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Clarityne Market Report by Segment

By Product

• Loratadine Tablets 

• Loratadine Capsules

By End-User

    • Adult

    • Pediatric

Global Clarityne Market by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa